Differentiating and apoptotic dose-dependent effects in (-)-alpha-bisabolol-treated human endothelial cells

J Nat Prod. 2010 Apr 23;73(4):523-6. doi: 10.1021/np9003933.

Abstract

The effect on angiogenesis of (-)-alpha-bisabolol [(-)-6-methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol] (1), a widely distributed plant sesquiterpene alcohol, was investigated for the first time. Human endothelial cells treated with 1 were analyzed for their ability to differentiate and organize in microvessels and for their sensitivity to this compound in terms of cytotoxicity and cell growth inhibition. Within 24 h of the treatment with 5 microM 1, cells underwent massive death. Apoptosis induction was responsible for cytotoxicity triggered by 1 as revealed by the release of cytochrome c from the mitochondria, reduction of the Bcl-2/Bax ratio, and caspase 3 activation. At a lower, non-apoptotic concentration (0.25 microM), 1 showed a differentiating effect resulting in growth inhibition, invasiveness reduction, and tubule stabilization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inducing Agents / pharmacology
  • Apoptosis / drug effects*
  • Cytochromes c / drug effects
  • Cytochromes c / metabolism
  • Dose-Response Relationship, Drug
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Humans
  • Mitochondria / enzymology
  • Monocyclic Sesquiterpenes
  • Proto-Oncogene Proteins c-bcl-2 / drug effects
  • Sesquiterpenes / chemistry*
  • Sesquiterpenes / pharmacology*
  • Stereoisomerism
  • bcl-2-Associated X Protein / drug effects

Substances

  • Angiogenesis Inducing Agents
  • Monocyclic Sesquiterpenes
  • Proto-Oncogene Proteins c-bcl-2
  • Sesquiterpenes
  • bcl-2-Associated X Protein
  • bisabolol
  • Cytochromes c